Primary sclerosing cholangitis, part 2: Cancer risk, prevention, and surveillance

James H. Tabibian, Ahmad H. Ali, Keith Lindor

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Primary sclerosing cholangitis (PSC) is a chronic, fibroinflammatory, progressive cholangiopathy. In a clinically significant proportion of patients, the disease course of PSC is punctuated by carcinogenesis, namely cholangiocarcinoma, gallbladder carcinoma, hepatocellular carcinoma, and/or colorectal carcinoma. Indeed, malignancy is arguably the most consequential sequela and the cause of nearly 50% of deaths in patients with PSC. This statistic is multifactorial, relating partly to the premalignant nature of PSC, challenges in diagnosis due to obscuration of cancer by the inflammation and fibrosis inherent to PSC, and the unpredictability of which type of cancer will develop in PSC and when. Here, in the second of a 2-part series, we review cancer risk, prevention, and surveillance in patients with PSC. We also discuss potential cancer surveillance strategies in PSC and, where evidence is limited, make pragmatic recommendations based on current data and expert opinion.

Original languageEnglish (US)
Pages (from-to)427-432
Number of pages6
JournalGastroenterology and Hepatology
Volume14
Issue number7
StatePublished - Jul 1 2018

Fingerprint

Sclerosing Cholangitis
Neoplasms
Cholangiocarcinoma
Expert Testimony
Gallbladder
Hepatocellular Carcinoma
Colorectal Neoplasms
Carcinogenesis
Fibrosis
Inflammation
Carcinoma

Keywords

  • Biliary tract neoplasm
  • Cirrhosis
  • Colorectal neoplasm
  • Early detection of cancer
  • Hepatocellular carcinoma
  • Inflammatory bowel disease

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Primary sclerosing cholangitis, part 2 : Cancer risk, prevention, and surveillance. / Tabibian, James H.; Ali, Ahmad H.; Lindor, Keith.

In: Gastroenterology and Hepatology, Vol. 14, No. 7, 01.07.2018, p. 427-432.

Research output: Contribution to journalArticle

@article{39eaa3b8a3d8453d95e82c6cce796fcc,
title = "Primary sclerosing cholangitis, part 2: Cancer risk, prevention, and surveillance",
abstract = "Primary sclerosing cholangitis (PSC) is a chronic, fibroinflammatory, progressive cholangiopathy. In a clinically significant proportion of patients, the disease course of PSC is punctuated by carcinogenesis, namely cholangiocarcinoma, gallbladder carcinoma, hepatocellular carcinoma, and/or colorectal carcinoma. Indeed, malignancy is arguably the most consequential sequela and the cause of nearly 50{\%} of deaths in patients with PSC. This statistic is multifactorial, relating partly to the premalignant nature of PSC, challenges in diagnosis due to obscuration of cancer by the inflammation and fibrosis inherent to PSC, and the unpredictability of which type of cancer will develop in PSC and when. Here, in the second of a 2-part series, we review cancer risk, prevention, and surveillance in patients with PSC. We also discuss potential cancer surveillance strategies in PSC and, where evidence is limited, make pragmatic recommendations based on current data and expert opinion.",
keywords = "Biliary tract neoplasm, Cirrhosis, Colorectal neoplasm, Early detection of cancer, Hepatocellular carcinoma, Inflammatory bowel disease",
author = "Tabibian, {James H.} and Ali, {Ahmad H.} and Keith Lindor",
year = "2018",
month = "7",
day = "1",
language = "English (US)",
volume = "14",
pages = "427--432",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "7",

}

TY - JOUR

T1 - Primary sclerosing cholangitis, part 2

T2 - Cancer risk, prevention, and surveillance

AU - Tabibian, James H.

AU - Ali, Ahmad H.

AU - Lindor, Keith

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Primary sclerosing cholangitis (PSC) is a chronic, fibroinflammatory, progressive cholangiopathy. In a clinically significant proportion of patients, the disease course of PSC is punctuated by carcinogenesis, namely cholangiocarcinoma, gallbladder carcinoma, hepatocellular carcinoma, and/or colorectal carcinoma. Indeed, malignancy is arguably the most consequential sequela and the cause of nearly 50% of deaths in patients with PSC. This statistic is multifactorial, relating partly to the premalignant nature of PSC, challenges in diagnosis due to obscuration of cancer by the inflammation and fibrosis inherent to PSC, and the unpredictability of which type of cancer will develop in PSC and when. Here, in the second of a 2-part series, we review cancer risk, prevention, and surveillance in patients with PSC. We also discuss potential cancer surveillance strategies in PSC and, where evidence is limited, make pragmatic recommendations based on current data and expert opinion.

AB - Primary sclerosing cholangitis (PSC) is a chronic, fibroinflammatory, progressive cholangiopathy. In a clinically significant proportion of patients, the disease course of PSC is punctuated by carcinogenesis, namely cholangiocarcinoma, gallbladder carcinoma, hepatocellular carcinoma, and/or colorectal carcinoma. Indeed, malignancy is arguably the most consequential sequela and the cause of nearly 50% of deaths in patients with PSC. This statistic is multifactorial, relating partly to the premalignant nature of PSC, challenges in diagnosis due to obscuration of cancer by the inflammation and fibrosis inherent to PSC, and the unpredictability of which type of cancer will develop in PSC and when. Here, in the second of a 2-part series, we review cancer risk, prevention, and surveillance in patients with PSC. We also discuss potential cancer surveillance strategies in PSC and, where evidence is limited, make pragmatic recommendations based on current data and expert opinion.

KW - Biliary tract neoplasm

KW - Cirrhosis

KW - Colorectal neoplasm

KW - Early detection of cancer

KW - Hepatocellular carcinoma

KW - Inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=85051011632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051011632&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:85051011632

VL - 14

SP - 427

EP - 432

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 7

ER -